SCHAERR JAFFE LLP

Lobbying for CELLPHIRE THERAPEUTICS, INC. · biotechnology company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Blood platelet technology and the Strategic National Stockpile

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem